Feed Top Reports Pricing

⌘K

07:24:58·52d

SECFiling

SEC Form 10-K filed by uniQure N.V.

QURE· uniQure N.V.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

QURE
uniQure N.V.
Health Care

Recent analyst ratings

Mar 11UpdateMizuho$35.00
Mar 9UpdateRBC Capital Mkts$35.00
Mar 9UpdateWells Fargo$60.00
Mar 3UpdateWells Fargo$15.00
Mar 3UpdateMizuho$12.00
Mar 2UpdateRBC Capital Mkts$11.00

Related

SEC7d
SEC Form PRE 14A filed by uniQure N.V.
ANALYST43d
uniQure upgraded by Mizuho with a new price target
INSIDER45d
Chief Customer & Strat Officer O'Keefe Kylie was granted 19,800 units of Ordinary Shares, increasing direct ownership by 19% to 124,800 units (SEC Form 4)
INSIDER45d
New insider O'Keefe Kylie claimed ownership of 105,000 units of Ordinary Shares (SEC Form 3)
ANALYST45d
uniQure upgraded by RBC Capital Mkts with a new price target
ANALYST45d
uniQure upgraded by Wells Fargo with a new price target
INSIDER48d
CEO, Managing Director Kapusta Matthew C was granted 70,600 units of Ordinary Shares and sold $132,104 worth of Ordinary Shares (14,581 units at $9.06), increasing direct ownership by 9% to 660,658 units (SEC Form 4)
INSIDER48d
Chief Medical Officer Abi-Saab Walid sold $7,320 worth of Ordinary Shares (808 units at $9.06) and was granted 41,700 units of Ordinary Shares, increasing direct ownership by 27% to 189,669 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022